EUVIMEDEUVIMED entdecken
Editorial

Decreasing the Risk of Heart Failure in a Changing Post–Myocardial Infarction Environment

Jean Rouleau

New England Journal of Medicine · 2024

DOI: 10.1056/nejme2402719 ↗

Kurz gefasst

Editorial in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von Jean Rouleau. Beteiligte Einrichtung: From the Montreal Heart Institute, University of Montreal, Montreal. Hauptthemen laut MEDLINE: Heart Failure, Myocardial Infarction, Cardiovascular Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A number of therapies that have been shown to be effective in patients with chronic heart failure, including beta-blockers, mineralocorticoid receptor antagonists, and renin–angiotensin system inhibitors, have also been shown to be beneficial in patients with evidence of left ventricular systolic dysfunction, pulmonary congestion, or both after an acute myocardial infarction. 1 However, the effectiveness of an agent in patients with chronic heart failure does not necessarily imply that the agent will be effective in patients who have had an acute myocardial infarction. For example, despite the effectiveness of sacubitril–valsartan in decreasing the risk of death from cardiovascular causes or hospitalization . . .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureMyocardial InfarctionCardiovascular AgentsHumansRisk FactorsHeart Disease Risk FactorsChronic DiseaseAngiotensin Receptor AntagonistsRamiprilAngiotensin-Converting Enzyme InhibitorsSodium-Glucose Transporter 2 InhibitorsStroke VolumeVentricular Dysfunction, LeftClinical Trials as TopicAminobutyratesBiphenyl CompoundsDrug CombinationsValsartanBenzhydryl CompoundsGlucosides

Substanzen

Cardiovascular AgentsAngiotensin Receptor AntagonistsRamiprilAngiotensin-Converting Enzyme InhibitorsSodium-Glucose Transporter 2 Inhibitorssacubitril and valsartan sodium hydrate drug combinationAminobutyratesBiphenyl CompoundsDrug CombinationsValsartan

Autor:innen und Institutionen

  • From the Montreal Heart Institute, University of Montreal, Montreal.

Zitieren

APA

Rouleau, J. (2024). Decreasing the Risk of Heart Failure in a Changing Post–Myocardial Infarction Environment. New England Journal of Medicine. https://doi.org/10.1056/nejme2402719

Vancouver

Rouleau J. Decreasing the Risk of Heart Failure in a Changing Post–Myocardial Infarction Environment. New England Journal of Medicine. 2024. doi:10.1056/nejme2402719

BibTeX
@article{Rouleau2024,
  author = {Rouleau, Jean},
  title = {Decreasing the Risk of Heart Failure in a Changing Post–Myocardial Infarction Environment},
  journal = {New England Journal of Medicine},
  year = {2024},
  doi = {10.1056/nejme2402719}
}
Kostenlos starten →